Noble Financial Reaffirms Outperform Rating for Tonix Pharmaceuticals (NASDAQ:TNXP)
Noble Financial restated their outperform rating on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note released on Thursday,Benzinga reports. The firm currently has a $70.00 price objective on the stock. Separately, StockNews.com started coverage on Tonix Pharmaceuticals in a research report on Monday, February 10th. They issued a “sell” rating on […]
Noble Financial restated their outperform rating on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note released on Thursday,Benzinga reports. The firm currently has a $70.00 price objective on the stock. Separately, StockNews.com started coverage on Tonix Pharmaceuticals in a research report on Monday, February 10th. They issued a “sell” rating on […]
